Cassava Sciences Inc (SAVA) Company Profile & Statistics

Cassava Sciences Inc
SAVA
(Nasdaq - US)
N/A
22.05
-0.01 (-0.04%)
in:usd•As of: May 03, 2024 15:59 UTC -4
After Market:22.05+0.00 (0.00%)
Open
22.19
High
22.35
Low
21.98

About Cassava Sciences Inc

CEO

Remi Barbier

Headquarters

6801 n. capital of texas highway, building 1; suite 300

austin, tx 78731, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.cassavasciences.com

Industry

biotechnology

Sector

health technology

Company Overview

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

Cassava Sciences Inc Statistics

Valuation Measures

Market Capitalization ²	953.66M
Enterprise Value	832.53M
Enterprise Value/EBITDA (ttm)	-7.97
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	6.76
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-57.53%
Return on Invested Capital (ttm)	-58.36%
Return on Assets (ttm)	-52.58%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-104.43M
Net Income Avi to Common (ttm)	-97.22M
Diluted EPS (ttm)	-2.32

Share Statistics

Beta (5Y Monthly)	-0.38
52-Week Change	-1.21%
S&P500 52-Week Change	26.43%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	43.23M
Dividend Yield	0.00%
Float ⁴	39.35M
% Held by Insiders	9.00%
% Held by Institutions	38.05%

Balance Sheet

Total Cash (mrq)	121.14M
Total Cash Per Share (mrq)	2.80
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	9.13%
Quick Ratio (mrq)	9.13%
Book Value Per Share (mrq)	3.25

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.96
Free Cash Flow (ytd)	-82.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Cassava Sciences Inc

Trade With A Regulated Broker